Tokio Marine Asset Management Co. Ltd. Has $56.41 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Key Points

• Tokio Marine Asset Management Co. Ltd. increased its stake in UnitedHealth Group by 3.1%, now holding 107,701 shares valued at approximately $56.41 million, making it the company's 7th largest position.
• UnitedHealth Group's CFO, John F. Rex, purchased 17,175 shares at an average price of $291.12, indicating a significant investment totaling nearly $5 million.
• The firm recently reported a quarterly earnings per share (EPS) of $4.08, which fell short of analysts' expectations by 37 cents, amidst a revenue of $111.62 billion.

Tokio Marine Asset Management Co. Ltd. grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 3.1% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 107,701 shares of the healthcare conglomerate's stock after acquiring an additional 3,211 shares during the period. UnitedHealth Group comprises 2.0% of Tokio Marine Asset Management Co. Ltd.'s investment portfolio, making the stock its 7th biggest position. Tokio Marine Asset Management Co. Ltd.'s holdings in UnitedHealth Group were worth $56,408,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Brighton Jones LLC lifted its stake in UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after purchasing an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC lifted its stake in UnitedHealth Group by 137.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock worth $2,033,000 after purchasing an additional 2,324 shares in the last quarter. Bank Pictet & Cie Europe AG lifted its stake in UnitedHealth Group by 3.9% in the 4th quarter. Bank Pictet & Cie Europe AG now owns 263,655 shares of the healthcare conglomerate's stock worth $133,373,000 after purchasing an additional 9,872 shares in the last quarter. Cohen & Steers Inc. lifted its stake in UnitedHealth Group by 36.1% in the 4th quarter. Cohen & Steers Inc. now owns 656 shares of the healthcare conglomerate's stock worth $332,000 after purchasing an additional 174 shares in the last quarter. Finally, Carroll Investors Inc lifted its stake in UnitedHealth Group by 174.4% in the 4th quarter. Carroll Investors Inc now owns 1,273 shares of the healthcare conglomerate's stock worth $646,000 after purchasing an additional 809 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the stock. Truist Financial lowered their price objective on shares of UnitedHealth Group from $360.00 to $345.00 and set a "buy" rating on the stock in a research report on Wednesday, July 16th. Mizuho lowered their price objective on shares of UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating on the stock in a research report on Friday, May 16th. Argus cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Monday, April 21st. UBS Group reiterated a "buy" rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Finally, Baird R W cut shares of UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research report on Thursday, July 31st. Three analysts have rated the stock with a sell rating, seven have issued a hold rating and fifteen have assigned a buy rating to the company's stock. According to data from MarketBeat, UnitedHealth Group presently has an average rating of "Hold" and a consensus target price of $366.52.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, CFO John F. Rex bought 17,175 shares of the business's stock in a transaction that occurred on Friday, May 16th. The stock was bought at an average cost of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the transaction, the chief financial officer owned 203,796 shares of the company's stock, valued at $59,329,091.52. This represents a 9.20% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Kristen Gil bought 3,700 shares of the business's stock in a transaction that occurred on Thursday, May 15th. The shares were acquired at an average price of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the transaction, the director directly owned 3,818 shares of the company's stock, valued at $1,035,327.06. This trade represents a 3,135.59% increase in their position. The disclosure for this purchase can be found here. Insiders bought 107,575 shares of company stock valued at $31,022,334 over the last ninety days. Company insiders own 0.28% of the company's stock.

UnitedHealth Group Trading Up 3.7%

Shares of NYSE UNH opened at $261.59 on Wednesday. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The stock has a market cap of $237.30 billion, a P/E ratio of 11.33, a price-to-earnings-growth ratio of 1.63 and a beta of 0.43. The firm has a 50-day moving average of $289.94 and a 200 day moving average of $402.24. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. The firm's quarterly revenue was up 12.9% on a year-over-year basis. During the same period last year, the firm posted $6.80 earnings per share. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 3.4%. UnitedHealth Group's payout ratio is 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.